Hyperthermia Heating Research Articles

Magnetic heating of interacting nanoparticles under different driving field waveforms

This study explores the impact of different magnetic driving field waveforms on nanoparticle heating in magnetic hyperthermia. Our research, which shifts the usual focus from individual nanoparticle properties to interacting particle clusters, evidences that square waves induce more uniform and greater heating than sinusoidal waves. The sequential switching observed with sinusoidal waves, which additionally strongly depends on the alignment of the particle cluster with respect to the direction of the field, leads to less uniform heating within and among different clusters. In contrast, a square waveform leads to simultaneous particle switching, thereby homogenizing the heat and potentially mitigating hazardous hot spots. These findings reaffirm the potential advantages for magnetic hyperthermia treatments using non-harmonic field waveforms, offering more uniform heating and the possibility of reducing the applied field exposure.

Hydrazine metal complexes as a single source in the mechanochemical preparation of metallic magnetic nanoparticles and investigation of their magnetic hyperthermia properties

Ferromagnetic metallic cobalt and nickel nanoparticles were synthesized by intramolecular metal-hydrazine ligand oxidation reduction reaction in basic media and the solid state. Nickel nanoparticles Ni1 and Ni2 are obtained from two complexes, Ni(N2H4)2(C2O4) and Ni(N2H4)2(HCO2)2, respectively. X-ray powder diffraction (XRD) and energy-dispersive X-ray (EDX) data show pure fcc crystal structures of nanoparticles. Scanning electron microscopy (SEM) images revealed both Ni1 and Ni2 nanoparticles have agglomerated sphere morphologies. The crystallite size estimated by using the Scherer method for Ni1 and Ni2 were 18.7 and 6.2 nm. Vibrating sample magnetometer (VSM) data show the coercivity of metallic nickel samples Ni1 and Ni2 are 50 and 153 Oe, respectively. Both nanoparticles cause an increase in the temperature of water under applied alternative magnetic field and showed specific loss power (SLP) of 70 W/g and 104.8 W/g, respectively. The same method is used in preparation of cobalt nanoparticles from two complexes, Co(N2H4)2(C2O4) and Co(N2H4)2(HCO2)2. XRD analysis data show both nanoparticles have hcp crystal structure. SEM images show nanosheet structure with sheet thickness of 10 to 30 nm. Coercivity of Co1 and Co2 nanoparticles obtained by VSM and Hc are 182 and 171 Oe, respectively. In spite of high coercivity in both Co1 and Co2 nanoparticles, the magnetic hyperthermia heating effects are not observed in practice and specific loss power (SLP) is zero.

Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists

A series of 1,4-benzoxazin-3-one analogs were investigated to discover mode-selective TRPV1 antagonists, since such antagonists are predicted to minimize target-based adverse effects. Using the high-affinity antagonist 2 as the lead structure, the structure activity relationship was studied by modifying the A-region through incorporation of a polar side chain on the benzoxazine and then by changing the C-region with a variety of substituted pyridine, pyrazole and thiazole moieties. The t-butyl pyrazole and thiazole C-region analogs provided high potency as well as mode-selectivity. Among them, antagonist 36 displayed potent and capsaicin-selective antagonism with IC50 = 2.31 nM for blocking capsaicin activation and only 47.5 % inhibition at 3 µM concentration toward proton activation, indicating that more than a 1000-fold higher concentration of 36 was required to inhibit proton activation than was required to inhibit capsaicin activation. The molecular modeling study of 36 with our homology model indicated that two π-π interactions with the Tyr511 and Phe591 residues by the A- and C-region and hydrogen bonding with the Thr550 residue by the B-region were critical for maintaining balanced and stable binding. Systemic optimization of antagonist 2, which has high-affinity but full antagonism for activators of all modes, led to the mode-selective antagonist 36 which represents a promising step in the development of clinical TRPV1 antagonists minimizing side effects such as hyperthermia and impaired heat sensation.

Association of malignant hyperthermia and exertional heat illness in young athletes: An analysis of awareness among clinical and athletic first responders.

Malignant hyperthermia (MH), a rare inherited condition seen almost exclusively in the perioperative setting, is triggered by volatile anesthetics or an intravenous paralytic drug, succinylcholine. It can, however, occur without any exposure to anesthetic drugs, being associated with heat illness and rhabdomyolysis, thus presenting a little-known risk to young athletes exercising in hot environments. This study aimed to determine the first responder awareness of MH and its association with heat illness in young athletes within athletic and clinical environments. Awareness within the clinical milieu was assessed by an institutional chart review of 3296 charts. The identified heat illness cases were examined for treatment consistent with the management of a suspected episode of MH. Awareness among first responders in an athletic setting was examined by a survey administered to a total of 1,500 coaches and athletic trainers at the high school level along with emergency medical services providers across the United States. No treatment consistent with the suspicion of MH was noted among clinical first responders, suggesting a lack of awareness. Survey administration also revealed a limited amount of knowledge of MH and its potential role in heat illness. The results point to lack of awareness among pre-hospital and hospital-based first responders of the relationship between MH and heat illness in young athletes. An effort to educate these members of the healthcare community can contribute to an expeditious and life-saving intervention. First responders who may interact with a young athlete have low knowledge of MH and its relationship to heat illness. Similar lack of awareness exists among hospital personnel who care for young individuals with heat illness. Educating the first responders about this condition can speed up the time to intervene and save lives.

Performance evaluation of dextran-coated CaFe12O19/MnFe2O4 exchange-spring composites for the self-heating properties at radio frequency field.

The CaFe12O19/MnFe2O4 composites with the hard (CaFe12O19) and soft (MnFe2O4) magnetic phases, were prepared by chemical co-precipitation method. The prepared composites were calcined at three different temperatures to form different phases. The structural, morphological, and magnetic properties of composite were analyzed by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), room temperature vibrational sample magnetometer (VSM), and transmission electron microscopy (TEM). The presence of the hard and soft phases has been confirmed without any secondary phase from XRD analysis, indicating the formation of composite. The crystallite size is found to be in the range of 24-44nm calculated by Scherrer's formula. The TEM revealed hexagonal platelets of CaFe12O19 with spinel MnFe2O4 particles with an average particle size of 48nm formed at the surface of the CaFe12O19/MnFe2O4 composite. The room temperature magnetic properties of composite were evaluated by employing VSM. The magnetic measurements have displayed enhancement in coercivity and magnetization for CaFe12O19/MnFe2O4, indicating that the composite possessed excellent exchange coupling. The composite's enhanced energy product ((BH)max) made it highly promising for biomedical applications such as hyperthermia. The exchange-spring coupled magnetic composite was coated with dextran to make it biocompatible, which is necessary for hyperthermia applications. The coating was confirmed using Fourier transform infrared spectroscopy (FTIR). Cytotoxicity tests on Vero cell lines showed that the coated composites had an excellent (>95%) cell survival rate. The hyperthermia heating of composite was measured for different concentrations of composite (0.25, 0.5, 1, 2, and 4mg/mL) from which specific loss power (SLP) was calculated. From these SLP values, the optimized concentration was identified.

Hyperthermia heating efficiency of glycine functionalised graphene oxide modified nickel nanoparticles

Hyperthermia has attracted significant attention as a potential low-cost and safe approach to cancer therapy. The development of highly efficient magnetic materials is pivotal for significantly broadening the application of this method. The present work describes the hyperthermia heating efficiency of sol-gel synthesized nickel nanoparticles and their functionalized moieties. Inclusion of nickel nanoparticles inside graphene oxide sheets and further functionalization with glycine were carried out to reduce the cytotoxicity of the magnetic nanoparticle. Vibrating Sample Magnetometer measurements (VSM) illustrate the ferromagnetic nature of all the samples. Saturation magnetization was found to be 40 emu/g and 13 emu/g for bare nickel nanoparticle and glycine functionalised graphene oxide modified nickel nanoparticle respectively. The magnetic nanomaterials showed good potential for hyperthermia applications, with a specific absorption rate of 63 W/g and 23 W/g for nickel nanoparticles and glycine functionalised graphene oxide modified nickel nanoparticles, respectively. The in-vitro cytotoxicity of the functionalised nickel nanoparticles on normal cells was examined in terms of cell viability. The percentage viability of 94.55 at higher concentration highlights the nontoxic nature of the functionalised material. The results taken together suggest that sol-gel synthesis of nickel nanoparticles with proper functionalization is appropriate for biomedical applications, especially for magnetic hyperthermia cancer therapy.

Thermoregulation during Field Exercise in Horses Using Skin Temperature Monitoring.

Hyperthermia and exertional heat illness (EHI) are performance and welfare issues for all exercising horses. Monitoring the thermoregulatory response allows for early recognition of metabolic heat accumulation during exercise and the possibility of taking prompt and effective preventative measures to avoid a further increase in core body temperature (Tc) leading to hyperthermia. Skin temperature (Tsk) monitoring is most used as a non-invasive tool to assess the thermoregulatory response pre- and post-exercise, particularly employing infrared thermographic equipment. However, only a few studies have used thermography to monitor skin temperature continuously during exercise. This commentary provides an overview of studies investigating surface skin temperature mainly by infrared thermography (IRT) during exercise. The scientific evidence, including methodologies, applications, and challenges associated with (continuous) skin temperature monitoring in horses during field exercise, is discussed. The commentary highlights that, while monitoring Tsk is straightforward, continuous Tsk alone does not always reliably estimate Tc evolvement during field exercise. In addition, inter-individual differences in thermoregulation need to be recognized and accounted for to optimize individual wellbeing. With the ongoing development and application of advanced wearable monitoring technology, there may be future advances in equipment and modeling for timely intervention with horses at hyperthermic risk to improve their welfare. However, at this point, infrared thermographic assessment of Tsk should always be used in conjunction with other clinical assessments and veterinary examinations for a reliable monitoring of the welfare of the horse.

Investigation of the suitability of zinc-doped cobalt ferrite as hyperthermia heating and MRA contrast agent

Investigation of the suitability of zinc-doped cobalt ferrite as hyperthermia heating and MRA contrast agent

Application of the ESHO-QA guidelines for determining the performance of the LCA superficial hyperthermia heating system

Purpose This study aimed to assess the quality of the lucite cone applicator (LCA), the standard applicator for superficial hyperthermia at the Erasmus MC Cancer Institute, using the most recent quality assurance guidelines, thus verifying their feasibility. Materials and methods The assessment was conducted on each of the six LCAs available for clinical treatments. The temperature distribution was evaluated using an infrared camera across different layers of a fat-muscle mimicking phantom. The maximum temperature increase, thermal effective penetration depth (TEPD), and thermal effective field size (TEFS) were used as quality metrics. The experimental results were validated through comparison with simulated results, using a canonical phantom model and a realistic phantom model segmented from CT imaging. Results A maximum temperature increase above 6 °C at 2 cm depth in the fat-muscle phantom for all the experiments was found. A mean negative difference between simulated and experimental data was of 1.3 °C when using the canonical phantom model. This value decreased to a mean negative difference of 0.4 °C when using the realistic model. Simulated and measured TEPD showed good agreement for both in silico scenarios, while discrepancies were present for TEFS. Conclusions The LCAs passed all QA guidelines requirements for superficial hyperthermia delivery when used singularly or in an array configuration. A further characterization of parameters such as antenna efficiency and heat transfer coefficients would be beneficial for translating experimental results to simulated values. Implementing the QA guidelines was time-consuming and demanding, requiring careful preparation and correct setup of antenna elements.

Proliferation and differentiation of MC3T3-E1 cells on polymethyl methacrylate cements containing Fe3O4 and TiO2 for hyperthermic treatment of metastatic bone tumors.

Polymethyl methacrylate (PMMA) bone cement is widely used to relieve pain caused by metastatic bone tumors. We previously found that PMMA bone cement containing 15 mass% or more of TiO2 showed good apatite-forming ability, and 25 mass% or more of Fe3O4 generated sufficient heat for hyperthermia under an alternating current (AC) magnetic field. In this study, the cytocompatibility of PMMA bone cement with Fe3O4:TiO2 weight ratios of 25:15 (F25T15-3/2-42) and 30:15 (F30T15-3/2-42) was evaluated using osteoblastic cells (MC3T3-E1). The proliferation and differentiation of MC3T3-E1 cells were suppressed for F25T15-3/2-42 and F30T15-3/2-42 compared to PMMA bone cement without Fe3O4 and TiO2 (F0T0-3/2-42). The release of methyl methacrylate (MMA) monomers from F25T15-3/2-42 and F30T15-3/2-42 at 7days was about 33 and 50times higher than that from F0T0-3/2-42, respectively. The remarkable release of MMA monomers from F25T15-3/2-42 and F30T15-3/2-42 may be responsible for the suppressed proliferation and differentiation of MC3T3-E1 cells. The release of MMA monomers was not reduced when the MMA/PMMA weight ratio was decreased from 3/2 to 1/1, however, it was significantly reduced by increasing the content of benzoyl peroxide (BPO) and N, N-dimethyl-p-toluidine (DMPT) to 8 and 4 mass% against MMA, respectively. Proliferation and differentiation of MC3T3-E1 cells on PMMA-type cements containing Fe3O4 and TiO2 with increased BPO and DMPT contents need to be investigated in the future; however, our findings will be useful for designing PMMA cements for the hyperthermic treatment of metastatic bone tumors.

Physical properties with high specific loss power of magnetite (Fe3O4) synthesized via thermal decomposition technique

Magnetic iron oxide nanoparticles have versatile applications in biomedical science that require control over shape and size distribution. Thermal decomposition is one of the best methods for controlling the size and shape of produced nanoparticles (NPs). The size distribution can be tuned (5–30 nm) by varying the reaction environment such as precursor concentration, amount of solvent used, temperature ramp, and reflux time. Iron oleate was used as a precursor solution and heated up to reflux temperature (310 °C) for 10 min within the oxygen-free environment by applying N2 gas flow. The XRD pattern confirmed the formation of NPs with a crystallite size of 17 ± 2.45 nm. Transmission electron microscope images showed moderately cubic shapes with a mean particle size of 28.67 ± 7.12 nm. Magnetic properties such as saturation magnetization, coercivity, and remanence were calculated at 23.48 emu/gm, 33 Oe, and 0.6 emu/gm, respectively, which indicated the ferromagnetic nature of the NPs. The Verwey transition was identified from the magnetization vs temperature (FC-ZFC) plot. The bondings of the oleic acid surfactant with the produced NPs were confirmed from Fourier transformation infrared spectroscopy (FTIR) data analysis. For the application of hyperthermia, the hydrophobic phase was transferred to the hydrophilic phase using cetyltrimethylammonium bromide, which was assured by the FTIR data analysis. The hyperthermia heating of NPs was measured for different concentrations of NPs (0.25, 0.5, 1, 2, and 4 mg/ml), from which specific loss power (SLP) was calculated. Among them, 0.25 mg/ml produced the most prominent SLP (2149 ± 309 w/g) that can be applied for targeted cancer treatment.

Nonspecific eddy current heating in magnetic field hyperthermia

In this Perspective article, we explore the definition and use of clinical tolerability metrics associated with nonspecific eddy current heating in magnetic field hyperthermia (MFH). We revisit the origins of the “Brezovich criterion,” Hof ≤ 485 MA m−1s−1, as it is applied to axial time-varying magnetic fields H (t) = Ho sin(2πft) and the human torso. We then consider alternative metrics, including the “maximal specific absorption rate” (SARmax) of eddy-current-induced power absorbed per unit mass of tissue. With reference to previously published clinical data and the results of two volunteer studies in our laboratory, we show that the SARmax metric is both suitable and reliable. We also show how it may be extracted from in silico finite element models to cope with confounding effects such as anatomical hot spots and non-axial-field geometries. We note a parallel with a standardized metric, the “local SAR” used in magnetic resonance imaging (MRI). We suggest that the limits established in clinical MRI (that the local SAR, averaged over 10 g of tissue and 6 min of treatment, should not exceed 20 mW g−1 in the torso or head, and 40 mW g−1 in the limbs) might be regarded as a good starting point for the design of MFH interventions. We conclude with the recommendation that the SARmax metric is adopted for future use in the development of clinically safe and tolerable MFH equipment.

МОДЕЛЮВАННЯ ПРОЦЕСУ ІНДУКЦІЙНОГО НАГРІВУ ДЛЯ СИСТЕМ МАГНІТНОЇ ГІПЕРТЕРМІЇ

The paper is devoted to the challenges of applying the induction heating (IH) for magnetic hyperthermia. The analysis of the results of previous studies has shown that within the biologically safe range of AC magnetic fields, insufficient induction heating power still appears to be one of the key problems for the successful clinical application of magnetic hyperthermia. In this paper, several possible effective circuit design solutions for the IH system are proposed, and their influence on the parameters of the heating processes of ferrites and ferromagnets is investigated. The model of the induction heater created in COMSOL Multiphysics allowes to simulate the distribution of current density and temperature in the heater. The developed model ensures better assessment of the processes occurring in living tissues and enables to simulate the impact of the magnetic particle material type and size on the temperature of heating and power consumption of the device.

Trends and perspectives on the commercialization of bioactive glasses.

At least 25 bioactive glass (BG) medical devices have been approved for clinical use by global regulatory agencies. Diverse applications include monolithic implants, bone void fillers, dentin hypersensitivity agents, wound dressing, and cancer therapeutics. The morphology and delivery systems of bioactive glasses have evolved dramatically since the first devices based on 45S5 Bioglass®. The particle size of these devices has generally decreased with the evolution of bioactive glass technology but primarily lies in the micron size range. Morphologies have progressed from glass monoliths to granules, putties, and cements, allowing medical professionals greater flexibility and control. Compositions of these commercial materials have primarily relied on silicate-based systems with varying concentrations of sodium, calcium, and phosphorus. Furthermore, therapeutic ions have been investigated and show promise for greater control of biological stimulation of genetic processes and increased bioactivity. Some commercial products have exploited the borate and phosphate-based compositions for soft tissue repair/regeneration. Mesoporous BGs also promise anticancer therapies due to their ability to deliver drugs in combination with radiotherapy, photothermal therapy, and magnetic hyperthermia. The objective of this article is to critically discuss all clinically approved bioactive glass products. Understanding essential regulatory standards and rules for production is presented through a review of the commercialization process. The future of bioactive glasses, their promising applications, and the challenges are outlined. STATEMENT OF SIGNIFICANCE: Bioactive glasses have evolved into a wide range of products used to treat various medical conditions. They are non-equilibrium, non-crystalline materials that have been designed to induce specific biological activity. They can bond to bone and soft tissues and contribute to their regeneration. They are promising in combating pathogens and malignancies by delivering drugs, inorganic therapeutic ions, and heat for magnetic-induced hyperthermia or laser-induced phototherapy. This review addresses each bioactive glass product approved by regulatory agencies for clinical use. A review of the commercialization process is also provided with insight into critical regulatory standards and guidelines for manufacturing. Finally, a critical evaluation of the future of bioactive glass development, applications, and challenges are discussed.

Modern definition of bioactive glasses and glass-ceramics

Bioactive glasses (BGs) and glass-ceramics (BGCs) have become a diverse family of materials being applied for treatment of many medical conditions. The traditional understanding of bioactive glasses and glass-ceramics pins them to bone-bonding capability without considering the other fields where they excel, such as soft tissue repair. We attempt to provide an updated definition of BGs and BGCs by comparing their structure, processing, and properties to those of other biomaterials. The proposed modern definition allows for consideration of all applications where the BGs and BGCs are currently used in the clinic and where the future of these promising biomaterials will grow. The new proposed definition of a bioactive glass is “a non-equilibrium, non-crystalline material that has been designed to induce specific biological activity”. The proposed definition of a bioactive glass-ceramic is “an inorganic, non-metallic material that contains at least one crystalline phase within a glassy matrix and has been designed to induce specific biological activity.” BGs and BGCs can bond to bone and soft tissues or contribute to their regeneration in many applications such as orthopedic, dentistry and wound repair. They can also deliver a specified concentration of inorganic therapeutic ions, heat for magnetic-induced hyperthermia or laser-induced phototherapy, radiation for brachytherapy, and drug delivery to combat pathogens and cancers.

Surfactant-driven optimization of iron-based nanoparticle synthesis: a study on magnetic hyperthermia and endothelial cell uptake.

This work examines the effect of changing the ratio of different surfactants in single-core iron-based nanoparticles with respect to their specific absorption rate in the context of magnetic hyperthermia and cellular uptake by human umbilical vein endothelial cells (HUVEC). Three types of magnetic nanoparticles were synthesized by separately adding oleic acid or oleylamine or a mixture of both (oleic acid/oleylamine) as surfactants. A carefully controlled thermal decomposition synthesis process led to monodispersed nanoparticles with a narrow size distribution. Spherical-shaped nanoparticles were mainly obtained for those synthesized with oleic acid, while the shape changed upon adding oleylamine. The combined use of oleic acid and oleylamine as surfactants in single-core iron-based nanoparticles resulted in a substantial saturation magnetization, reaching up to 140 A m2 kg-1 at room temperature. The interplay between these surfactants played a crucial role in achieving this high magnetic saturation. By modifying the surface of the magnetic nanoparticles using a mixture of two surfactants, the magnetic fluid hyperthermia heating rate was significantly improved compared to using a single surfactant type. This improvement can be attributed to the larger effective anisotropy achieved through the modification with both (oleic acid/oleylamine). The mixture of surfactants enhances the control of interparticle distance and influences the strength of dipolar interactions, ultimately leading to enhanced heating efficiency. Functionalization of the oleic acid-coated nanoparticles with trimethoxysilane results in the formation of a core-shell structure Fe@Fe3O4, showing exchange bias (EB) associated with the exchange anisotropy between the shell and the core. The biomedical relevance of our synthesized Fe@Fe3O4 nanoparticles was demonstrated by their efficient uptake by human umbilical vein endothelial cells (HUVECs) in a concentration-dependent manner. This remarkable cellular uptake highlights the potential of these nanoparticles in biomedical applications.

Microstrip coils for MR‐imaging with induced RF heating for hyperthermia

Microstrip coils for MR‐imaging with induced <scp>RF</scp> heating for hyperthermia

Analysis of Heat Propagation on Difference Size of Malignant Tumor

Cancer is one of the leading causes of death in Malaysia as reported by the Malaysia National Cancer. Statistical data showed that breast cancer has the highest percentage over the other cancers in Malaysia Treatment such as hyperthermia therapy is introduced as an alternative treatment to increase the efficiency of radiotherapy and chemotherapy. This procedure exposes the malignant tissue to a high temperature between 40 to 44 degrees Celsius This study focuses on how different heat sources affect the heat propagation of malignant breast tumours. The malignant breast tumour of different sizes also will be considered in this study. The heat propagation was simulated using the computational fluid dynamic (CFD) method. Infrared sources are imposed in this study. The transient Pennes Heat equation is also applied to solve the heat generation Velocity and pressure in the blood vessel have no significant changes for all models. In summary, this study will predict the hyperthermic heat propagation efficiency onto the malignant tissue as well as predict the optimum heat generation on the malignant tumour.

Synthesised Conductive/Magnetic Composite Particles for Magnetic Ablations of Tumours.

Ablation is a clinical cancer treatment, but some demands are still unsatisfied, such as electromagnetic interferences amongst multiple ablation needles during large tumour treatments. This work proposes a physical synthesis for composite particles of biocompatible iron oxide particles and liquid metal gallium (Ga) with different alternative-current (AC)-magnetic-field-induced heat mechanisms of magnetic particle hyperthermia and superior resistance heat. By some imaging, X-ray diffraction, and vibrating sample magnetometer, utilised composite particles were clearly identified as the cluster of few iron oxides using the small weight ratio of high-viscosity liquid metal Ga as conjugation materials without surfactants for physical targeting of limited fluidity. Hence, well penetration inside the tissue and the promotion rate of heat generation to fit the ablation requirement of at least 60 °C in a few seconds are achieved. For the injection and the post-injection magnetic ablations, the volume variation ratios of mice dorsal tumours on Day 12 were expressed at around one without tumour growth. Its future powerful potentiality is expected through a percutaneous injection.

Synthesis of magneto-plasmonic hybrid material for cancer hyperthermia

Magnetic nanoparticle CoFe2O4-based hyperthermia is a promising non-invasive approach for cancer therapy. However, CoFe2O4 nanoparticles (NPs) have a low heat transfer efficiency, which limits their practical clinical applications. Hence, it is necessary to investigate the higher-performance magnetic NPs-based hybrid nanostructures to enhance their magnetic hyperthermia efficiency. This work presents a facile in situ approach for synthesizing cobalt ferrite (CoFe2O4) silver (Ag) hybrid NPs as optical-magnetic hyperthermia heat mediators. The prepared cobalt ferrite silver hybrid NPs exhibit a higher heat generation than that of individual Ag or CoFe2O4 NPs under simultaneous exposure to an alternating current magnetic field and laser source. The obtained results confirm that the hybridization of CoFe2O4 and Ag NPs could significantly enhance the hyperthermia efficiency of the prepared NPs. Therefore, the CoFe2O4-Ag hybrid NPs are considered as potential candidates for a high-performance hyperthermia mediator based on a simple and effective synthesis approach.